Groundbreaking First-in-Human Study Demonstrates Potential to Treat Type 1 Diabetes by Transplanting Insulin-Secreting Cells Without ...

A man came up behind a Fox 19 reporter and took a drag of a cigarette before devouring it during the live broadcast.

Biotech and drug-innovation themes continue to dominate markets—from AI-driven drug discovery to blockbuster obesity treatments—and a new ETF filing suggests asset managers want a piece of that ...

The trial clearance for Shanghai-based Unixell is another step forward for the rapidly advancing Chinese biotech ecosystem, ...

By introducing proprietary, patent-protected, genetically engineered porcine organs into an organ transplant system, kidney xenotransplantation has the potential to alter many aspects of the system.

Chief Secretary Anu Garg on Friday said that the state would achieve its ambitious vision of a Viksit Odisha by 2036 by harnessing its huge potential in the blue economy.

East Boothbay, Maine, U.S.A.-based Bigelow Laboratory of Ocean Sciences has partnered with aquaculture investment firm Hatch Blue to launch “a first of its kind” blue biotech innovation studio to aid ...

Celcuity develops targeted cancer therapies and diagnostics, leveraging proprietary technology to advance precision oncology solutions.

The program, which launches in the fall, includes different pathways to be industry-ready, ranging from micro-credentials to a full associate degree. A $3 million lab modeled on real industry ...

This biotech specializes in precision therapies for rare genetic diseases, with a pipeline targeting oncology and hematology indications.

Rapid Micro Biosystems, Inc. sees strong FY25 revenue growth from Growth Direct placements, but losses persist. Click for more on RPID Q4 earnings results.

Coriolis Pharma, a global contract research and development organization, celebrated the grand opening of its new North America headquarters and laboratory, marking the start of operations at the ...